Plexus Corp Earnings Tomorrow: Whether Revenue Momentum Can Finally Translate to Margin Expansion
Plexus Corp. (PLXS) reports fiscal third-quarter 2026 earnings after the close on July 29, with analysts expecting $1.27 per share — a sharp 22.6% decline from the same quarter last year. The central question: can the electronics manufacturing services provider stabilize margins and demand amid a challenging macro environment, or will downward estimate revisions continue to pressure the stock?
Part 1: Earnings Preview
Plexus Corp. is a leading provider of electronic manufacturing services (EMS), designing and building complex products for customers in healthcare, industrial, aerospace/defense, and communications markets. The company operates globally, offering end-to-end solutions from design through aftermarket services.
Plexus is scheduled to report fiscal Q3 2026 results after the close on July 29, 2026. The consensus estimate stands at $1.27 per share, with estimates ranging from $1.16 to $1.33 across three analysts. The company most recently reported $1.82 per share for fiscal Q2 2026, beating estimates by 11.66%. However, the year-over-year comparison is concerning: the $1.27 estimate represents a 22.6% decline from the $1.64 reported in the same quarter last year (fiscal Q3 2025).
Three key themes define this earnings story:
1. Margin Pressure and Cost Management: Analysts have slashed estimates significantly — the prior consensus for this quarter was $1.64, now down to $1.27. This 22.6% reduction suggests concerns about margin compression, potentially driven by pricing pressure, unfavorable product mix, or operational inefficiencies. Investors will scrutinize whether management can stabilize gross margins through cost controls and operational improvements.
2. End-Market Demand Weakness: The sequential decline in estimates for both this quarter and next (down 25.1% year-over-year for fiscal Q4) points to softening demand across Plexus's key verticals. Healthcare and industrial markets may be experiencing inventory corrections or delayed capital spending, while aerospace/defense could face budget pressures. Management commentary on order trends and backlog will be critical.
3. Full-Year Guidance Reset: With fiscal year 2026 estimates now at $5.98 (down from a prior $6.41), representing a 6.7% decline from last year, investors need clarity on whether this represents a temporary trough or a more structural challenge. The outlook for fiscal 2027 — currently projected at $6.70 (+12% growth) — will determine whether the market views this as a cyclical bottom or the start of a longer downturn.
Analyst commentary ahead of the release has been cautious, with the average recommendation deteriorating from 3.29 to 3.57 over the past month (closer to Hold territory). One analyst downgraded from Strong Sell to Hold, suggesting some stabilization in bearish sentiment, but the wide price target range ($150 to $330) reflects significant uncertainty about the company's near-term trajectory.
Part 2: Historical Earnings Performance
Plexus has demonstrated a consistent pattern of beating earnings estimates over the past four quarters, with an average surprise of +10.91%. The company beat by +12.33% in fiscal Q3 2025 (reporting $1.64 vs. $1.46 estimate), followed by a strong +17.61% beat in fiscal Q4 2025 ($1.87 vs. $1.59), a modest +2.03% beat in fiscal Q1 2026 ($1.51 vs. $1.48), and most recently an +11.66% beat in fiscal Q2 2026 ($1.82 vs. $1.63).
Despite this track record of outperformance, the magnitude of beats has been inconsistent, ranging from just 2% to nearly 18%. The fiscal Q1 2026 result was particularly weak relative to the pattern, suggesting execution challenges or temporary headwinds. More concerning is the sequential decline in reported EPS from $1.87 in fiscal Q4 2025 to $1.51 in fiscal Q1 2026, followed by a recovery to $1.82 in fiscal Q2 2026 — indicating volatility in quarterly performance.
The current consensus of $1.27 for fiscal Q3 2026 represents a 30% decline from the $1.82 reported last quarter, which would be the sharpest sequential drop in this dataset. Even if Plexus delivers another double-digit beat, the result would still represent significant year-over-year deterioration. This suggests analysts have already baked in substantial weakness, but the bar for a positive surprise may be lower than the headline estimate implies.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $1.46 | $1.64 | +12.33% | Beat |
| Sep 2025 | $1.59 | $1.87 | +17.61% | Beat |
| Dec 2025 | $1.48 | $1.51 | +2.03% | Beat |
| Mar 2026 | $1.63 | $1.82 | +11.66% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Plexus reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 reflects the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-29 | +$4.27 (+1.73%) | $8.34 (3.39%) | -$0.02 (-0.01%) | $20.27 (8.09%) |
| 2026-01-28 | +$7.34 (+4.23%) | $8.22 (4.73%) | +$16.75 (+9.26%) | $19.26 (10.65%) |
| 2025-10-22 | -$4.23 (-2.81%) | $5.83 (3.88%) | +$3.76 (+2.57%) | $8.50 (5.82%) |
| 2025-07-23 | +$0.21 (+0.16%) | $1.85 (1.39%) | -$15.54 (-11.61%) | $12.19 (9.11%) |
| 2025-04-23 | +$3.06 (+2.47%) | $3.89 (3.13%) | -$1.82 (-1.43%) | $5.96 (4.69%) |
| 2025-01-22 | +$0.17 (+0.10%) | $2.78 (1.63%) | -$17.19 (-10.08%) | $9.40 (5.51%) |
| 2024-10-23 | +$0.79 (+0.59%) | $1.85 (1.38%) | +$9.32 (+6.87%) | $15.57 (11.48%) |
| 2024-07-24 | -$2.69 (-2.26%) | $4.90 (4.12%) | +$13.44 (+11.57%) | $12.21 (10.51%) |
| Avg Abs Move | 1.79% | 2.96% | 6.68% | 8.23% |
Plexus has exhibited highly volatile post-earnings price action, with an average absolute Day 0 move of 1.79% and Day +1 move of 6.68%. The Day +1 reaction has been particularly dramatic, with a range averaging 8.23%, indicating significant uncertainty and repositioning after results are digested.
The most recent earnings (April 2026) saw a modest +1.73% Day 0 move followed by essentially flat Day +1 action (-0.01%), suggesting the market had largely priced in the result. However, the January 2026 report triggered a +4.23% Day 0 move and a massive +9.26% Day +1 surge, reflecting a strong positive surprise. Conversely, the July 2025 report saw a muted Day 0 response (+0.16%) but a brutal -11.61% Day +1 decline, indicating disappointing guidance or commentary overshadowed the headline beat.
The directional pattern is mixed — four of the last eight reports saw Day +1 gains, while four saw declines, with no clear trend. The largest Day +1 moves have been double-digit swings (both up and down), suggesting the market reacts strongly to guidance and management commentary rather than just the headline EPS number. Given the sharp downward estimate revisions heading into this report, investors should prepare for a potentially outsized Day +1 reaction if results or guidance deviate meaningfully from the reset expectations.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 24) |
| Expected Move | $0.00 (0.00%) |
| Expected Range | $249.98 to $249.98 |
| Implied Volatility | 50.08% |
The options market is pricing in no expected move for the August 21 expiration (24 days out), which is unusual and likely reflects limited options liquidity or data availability for this specific contract. Historical earnings moves suggest investors should anticipate a Day +1 reaction in the 6-7% range, with potential for double-digit swings if results or guidance surprise significantly.
Part 3: What Analysts Are Saying
Analysts currently rate Plexus at an average of 3.57 (between Hold and Buy), with a mean price target of $267.40 — implying 6.9% upside from the current price of $250.08. The rating breakdown shows 1 Strong Buy, 2 Moderate Buys, 4 Holds, and no Sells, reflecting a cautiously optimistic but divided view on the stock.
Sentiment has improved over the past month, with one analyst upgrading from Strong Sell to Hold, reducing the sell-side pressure. However, the average recommendation has actually deteriorated slightly from 3.29 to 3.57 (moving closer to Hold territory), suggesting the upgrade was offset by other analysts becoming more cautious or reducing conviction.
The wide dispersion in price targets — ranging from a low of $150 to a high of $330 — underscores significant disagreement about Plexus's valuation and outlook. The $150 bear case implies 40% downside risk, while the $330 bull case suggests 32% upside potential. This 180-point spread reflects uncertainty around whether the current earnings downturn is cyclical (supporting the bull case for a recovery) or structural (validating the bear case for sustained weakness).
The consensus target of $267.40 sits well below the stock's recent trading levels, suggesting analysts believe the market may be pricing in too much optimism about a near-term recovery. With estimates continuing to decline and full-year guidance likely to be a focal point, analysts appear to be waiting for clearer evidence of stabilization before becoming more constructive.
Part 4: Technical Picture
The Barchart Technical Opinion currently shows a 40% Buy signal, unchanged from last week but down sharply from 96% Buy a month ago. This dramatic deterioration reflects significant technical damage as the stock has pulled back from recent highs and broken below key moving averages.
Timeframe Analysis:
- Short-term (Hold): Neutral signal indicates near-term momentum has stalled, with the stock consolidating after recent weakness
- Medium-term (50% Buy): Moderate buy signal suggests the intermediate-term trend remains intact but is losing strength
- Long-term (100% Buy): Strong buy signal reflects the stock's solid performance over the past year, with the 200-day moving average still providing support
Trend Characteristics: The Soft strength and Weakest direction indicate the uptrend is fragile and losing momentum heading into earnings, suggesting vulnerability to further downside if results disappoint.
Plexus is trading at $250.08, below its 5-day ($255.78), 10-day ($254.57), 20-day ($263.29), and 50-day ($272.82) moving averages, but above its 100-day ($248.84) and 200-day ($206.17) averages. This configuration shows the stock in a short-term downtrend after peaking near $273 in recent weeks, but still maintaining longer-term support.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $255.78 | 50-Day MA | $272.82 |
| 10-Day MA | $254.57 | 100-Day MA | $248.84 |
| 20-Day MA | $263.29 | 200-Day MA | $206.17 |
The breakdown below the 50-day moving average at $272.82 is technically significant, suggesting the stock has shifted from an uptrend to a consolidation or correction phase. The 100-day moving average at $248.84 now represents immediate support — a break below this level could trigger further selling toward the 200-day average at $206.17. Conversely, a strong earnings beat and guidance could propel the stock back above the 50-day average and reestablish the uptrend. The technical setup is cautionary heading into the report, with momentum indicators deteriorating and the stock vulnerable to further downside if results fail to stabilize sentiment. However, the long-term trend remains constructive, suggesting any earnings-driven selloff could present a buying opportunity for investors with a longer time horizon.